Table 1.
Wild-type BRAF group | V600E BRAF group | |
---|---|---|
n | 6 | 9 |
Gender | 5 men/1 woman | 7 men/2 women |
Median age, y (range) | 66 (42-78) | 55 (44-71) |
Stage | ||
III | 1 | 0 |
IV M1a | 2 | 4 |
IV M1b | 1 | 1 |
IV M1c | 2 | 4 |
Prior therapy* | ||
None | 1 | 0 |
Chemotherapy | 5 | 9 |
Adjuvant immunotherapy was not considered prior therapy for metastatic melanoma.